Ravi Rao
Director/Board Member en DBV TECHNOLOGIES .
Fortuna: 9 828 $ al 31/03/2024
Perfil
El Dr. Ravi M. Rao es director médico de Swedish Orphan Biovitrum AB y miembro del Royal College of Physicians. Forma parte del Consejo de Administración de DBV Technologies SA. Anteriormente, el Dr. Rao trabajó como Director Médico en Aeglea Biotherapeutics, Inc. y como Jefe de Asuntos Médicos Globales en GlaxoSmithKline Plc. Se licenció en la Universidad de Cambridge y se doctoró en el Imperial College de Londres.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
DBV TECHNOLOGIES SA
0.01% | 15/02/2023 | 6 837 ( 0.01% ) | 9 828 $ | 31/03/2024 |
Cargos activos de Ravi Rao
| Empresas | Cargo | Inicio |
|---|---|---|
| DBV TECHNOLOGIES | Director/Board Member | 19/05/2021 |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 01/04/2024 |
| The Royal College of Physicians | Corporate Officer/Principal | - |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01/04/2022 |
Antiguos cargos conocidos de Ravi Rao.
| Empresas | Cargo | Fin |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 01/01/2022 |
| SPYRE THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 10/08/2020 |
| GSK PLC | Chief Tech/Sci/R&D Officer | 01/10/2019 |
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | - |
Formación de Ravi Rao.
| Imperial College London | Doctorate Degree |
| University of Cambridge | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 6 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| DBV TECHNOLOGIES | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Empresas privadas | 1 |
|---|---|
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Ravi Rao
